Literature DB >> 29357128

Contribution of Adipose Tissue to Development of Cancer.

Alyssa J Cozzo1, Ashley M Fuller2, Liza Makowski1,3,4.   

Abstract

Solid tumor growth and metastasis require the interaction of tumor cells with the surrounding tissue, leading to a view of tumors as tissue-level phenomena rather than exclusively cell-intrinsic anomalies. Due to the ubiquitous nature of adipose tissue, many types of solid tumors grow in proximate or direct contact with adipocytes and adipose-associated stromal and vascular components, such as fibroblasts and other connective tissue cells, stem and progenitor cells, endothelial cells, innate and adaptive immune cells, and extracellular signaling and matrix components. Excess adiposity in obesity both increases risk of cancer development and negatively influences prognosis in several cancer types, in part due to interaction with adipose tissue cell populations. Herein, we review the cellular and noncellular constituents of the adipose "organ," and discuss the mechanisms by which these varied microenvironmental components contribute to tumor development, with special emphasis on obesity. Due to the prevalence of breast and prostate cancers in the United States, their close anatomical proximity to adipose tissue depots, and their complex epidemiologic associations with obesity, we particularly highlight research addressing the contribution of adipose tissue to the initiation and progression of these cancer types. Obesity dramatically modifies the adipose tissue microenvironment in numerous ways, including induction of fibrosis and angiogenesis, increased stem cell abundance, and expansion of proinflammatory immune cells. As many of these changes also resemble shifts observed within the tumor microenvironment, proximity to adipose tissue may present a hospitable environment to developing tumors, providing a critical link between adiposity and tumorigenesis. © 2018 American Physiological Society. Compr Physiol 8:237-282, 2018.
Copyright © 2018 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29357128      PMCID: PMC5806627          DOI: 10.1002/cphy.c170008

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  458 in total

1.  Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors.

Authors:  Kohsuke Takeda; Yoshihiro Sowa; Kenichi Nishino; Kyoko Itoh; Shinji Fushiki
Journal:  Ann Plast Surg       Date:  2015-06       Impact factor: 1.539

Review 2.  The two faces of IL-6 in the tumor microenvironment.

Authors:  Daniel T Fisher; Michelle M Appenheimer; Sharon S Evans
Journal:  Semin Immunol       Date:  2014-03-03       Impact factor: 11.130

3.  Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.

Authors:  Ondrej Mestak; Veronika Hromadkova; Monika Fajfrova; Martin Molitor; Jan Mestak
Journal:  Ann Surg Oncol       Date:  2015-10-14       Impact factor: 5.344

4.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile.

Authors:  Ricardo J T Ribeiro; Cátia P D Monteiro; Virginia F P M Cunha; Andreia S M Azevedo; Maria J Oliveira; Rosário Monteiro; Avelino M Fraga; Paulo Príncipe; Carlos Lobato; Francisco Lobo; António Morais; Vitor Silva; José Sanches-Magalhães; Jorge Oliveira; João T Guimarães; Carlos M S Lopes; Rui M Medeiros
Journal:  Cell Physiol Biochem       Date:  2012-03-01

6.  Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors.

Authors:  E M Chandler; M P Saunders; C J Yoon; D Gourdon; C Fischbach
Journal:  Phys Biol       Date:  2011-02-07       Impact factor: 2.583

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.

Authors:  Yulong He; Iiro Rajantie; Maritta Ilmonen; Taija Makinen; Marika J Karkkainen; Paula Haiko; Petri Salven; Kari Alitalo
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

10.  Role of adiponectin and its receptors in cancer.

Authors:  Stephanie Obeid; Lionel Hebbard
Journal:  Cancer Biol Med       Date:  2012-12       Impact factor: 4.248

View more
  64 in total

1.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

Review 2.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 3.  Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.

Authors:  Ernst Lengyel; Liza Makowski; John DiGiovanni; Mikhail G Kolonin
Journal:  Trends Cancer       Date:  2018-04-05

4.  Obesity, sleep apnea, and cancer.

Authors:  Isaac Almendros; Miguel A Martinez-Garcia; Ramon Farré; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-18       Impact factor: 5.095

Review 5.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

Review 6.  Addressing Patient Specificity in the Engineering of Tumor Models.

Authors:  Laura J Bray; Dietmar W Hutmacher; Nathalie Bock
Journal:  Front Bioeng Biotechnol       Date:  2019-09-12

7.  Synergism of Adipocytokine Profile and ADIPOQ/TNF-α Polymorphisms in NAFLD-associated MetS Predict Colorectal Liver Metastases Outgrowth.

Authors:  Rosa Divella; Antonella Daniele; Raffaele DE Luca; Antonio Mazzocca; Eustachio Ruggieri; Eufemia Savino; Porzia Casamassima; Michele Simone; Carlo Sabba; Angelo Paradiso
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

8.  Engineering of microscale vascularized fat that responds to perfusion with lipoactive hormones.

Authors:  Xuanyue Li; Jingyi Xia; Calin T Nicolescu; Miles W Massidda; Tyler J Ryan; Joe Tien
Journal:  Biofabrication       Date:  2018-10-30       Impact factor: 9.954

9.  Rethinking carcinogenesis: The detached pericyte hypothesis.

Authors:  Stuart G Baker
Journal:  Med Hypotheses       Date:  2020-06-30       Impact factor: 1.538

Review 10.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.